Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

about

Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor.

P2860

Q47611215-E9A85F3C-B3C9-44F9-AD7D-D05F9D0F9B11 Q50033979-884F7924-D15D-4ACE-9044-7C7D15995581

P2860

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

Item

http://www.wikidata.org/entity/Q39164366

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

@en

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

@nl

type

Item

label

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

@en

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

@nl

prefLabel

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

@en

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

@nl

P1476

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble

@en

P2093

Brasilina Caroccia

http://www.w3.org/2001/XMLSchema#string

Gail K Adler

http://www.w3.org/2001/XMLSchema#string

Gian Paolo Rossi

http://www.w3.org/2001/XMLSchema#string

Giuseppe Maiolino

http://www.w3.org/2001/XMLSchema#string

Maurizio Cesari

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin II, NADPH oxidase, and redox signaling in the vasculature

Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal.

Getting to the heart of the matter: new insights into cardiac fibrosis.

Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Aldosterone and cardiovascular disease.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Role of tissue angiotensin II in myocardial remodelling induced by mechanical stress.

Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling

P304

545-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.116.08956

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

T Seccia

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28264920

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

5425097

http://www.w3.org/2001/XMLSchema#string

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

about

P2860

P2860

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932